Yahoo
NYSE - Delayed Quote USD

Cardinal Health, Inc. (CAH)

247.18 -1.43 (-0.58%)
At close: September 4 at 4:00:02 PM EDT
248.47 +1.29 (+0.52%)
After hours: September 4 at 7:56:46 PM EDT
Trade CAH on Coinbase
Dividend
CAH announced a cash dividend of $0.516 with an ex-date of Oct. 1, 2026

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Jason M. Hollar
CEO & Director 5.54M -- 1973
Mr. Aaron E. Alt J.D.
Chief Financial Officer 2.23M -- 1973
Ms. Jessica L. Mayer
Chief Legal & Compliance Officer 1.72M 294.76k 1970
Mr. Stephen M. Mason
Chief Executive Officer of GMPD segment 1.39M 382.89k 1972
Ms. Deborah L. Weitzman
Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment 1.74M -- 1965
Ms. Mary C. Scherer
Senior VP & Chief Accounting Officer -- -- --
Mr. David Frost
Vice President of Investor Relations -- -- --
Ms. Valerie Christine Pitteroff
Chief Human Resources Officer -- -- --
Mr. Craig Cowman
President of Biopharma Solutions & Strategic Sourcing -- -- --
Mr. Ben Brinker
President of Global Operations & Supply Chain -- -- --

Cardinal Health, Inc.

7000 Cardinal Place
Dublin, OH 43017
United States
614 757 5000 https://www.cardinalhealth.com
Sector: 
Healthcare
Industry: 
Medical Distribution
Full Time Employees: 
58,788

Description

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Corporate Governance

Cardinal Health, Inc.’s ISS Governance QualityScore as of September 1, 2026 is 1. The pillar scores are Audit: 9; Board: 1; Shareholder Rights: 1; Compensation: 1.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

October 1, 2026 at 12:00 AM UTC

Ex-Dividend Date

October 15, 2026 at 12:00 AM UTC

Dividend Date

November 5, 2026 at 12:30 PM UTC

Cardinal Health, Inc. Earnings Date

Recent Events

August 11, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 5, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 23, 2026 at 12:00 AM UTC

11-K: Annual report of employee stock purchase

June 1, 2026 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

April 30, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 23, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 5, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 5, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 13, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 6, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: